Charles River Laboratories International Inc (NYSE:CRL)
$ 214.2 25.52 (13.53%) Market Cap: 10.95 Bil Enterprise Value: 13.50 Bil PE Ratio: 25.59 PB Ratio: 2.97 GF Score: 87/100

Charles River Laboratories International Inc at Jefferies Healthcare Conference Transcript

Jun 08, 2022 / 02:00PM GMT
Release Date Price: $236.9 (-4.17%)
Steven Couche
Jefferies LLC, Research Division - Equity Associate

Hello. Welcome to the 2022 Jefferies Healthcare Conference. My name is Steven Couche. I'm filling in for Dave Windley, who is in COVID quarantine prison, as he describes it. We are lucky to be joined here today by Jim Foster from Charles River, Chairman of the Board, President and Chief Executive Officer, and I think you'd like to lead it off with some comments.

Questions & Answers

James C. Foster
Charles River Laboratories International, Inc. - Chairman, CEO & President

Sure. Nice to be here, as always. We'll give Dave our regards. We had an 8-K this morning. So for those of you that missed that, I just thought I would give some context and some comments about that. So we talked about the fact that we still felt good about our guidance ranges for top and bottom line for the year.

We feel really good about the overall demand for our business and the power of our nonclinical portfolio, unique nonclinical portfolio. We talked specifically about the impact of our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot